Skip to main content
Erschienen in: Indian Journal of Surgical Oncology 4/2015

05.12.2015 | ORIGINAL ARTICLE

Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population

verfasst von: Naveen Padmanabhan, Muhamed Faizal Ayub, Khadher Hussain, Ann Kurien, Selvi Radhakrishna

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Current guidelines recommend completion axillary lymphnode dissection (ALND) when sentinel lymphnode (SLN) contains metastatic tumor deposit. In consequent ALND sentinel node is the only node involved by tumor in 40–70 % of cases. Recent studies demonstrate the oncologic safety of omitting completion ALND in low risk patients. Several nomograms (MSKCC, Stanford, MD Anderson score, Tenon score) had been developed in predicting the likelihood of additional nodes metastatic involvement. We evaluated accuracy of MSKCC nomogram and other clinicopathologic variables associated with additional lymph node metastasis in our patients. A total of 334 patients with primary breast cancer patients underwent SLN biopsy during the period Jan 2007 to June 2014. Clinicopathologic variables were prospectively collected. Completion ALND was done in 64 patients who had tumor deposit in SLN. The discriminatory accuracy of nomogram was analyzed using Area under Receiver operating characteristic curve (ROC). SLN was the only node involved with tumor in 69 % (44/64) of our patients. Additional lymph node metastasis was seen in 31 % (20/64). On univariate analysis, extracapsular infiltration in sentinel node and multiple sentinel nodes positivity were significantly associated (p < 0.05) with additional lymph node metastasis in the axilla. Area under ROC curve for nomogram was 0.58 suggesting poor performance of the nomogram in predicting NSLN involvement. Sentinel nodes are the only nodes to be involved by tumor in 70 % of the patients. Our findings indicate that multiple sentinel node positivity and extra-capsular invasion in sentinel node significantly predicted the likelihood of additional nodal metastasis. MSKCC nomogram did not reliably predict the involvement of additional nodal metastasis in our study population.
Literatur
1.
Zurück zum Zitat Petrek JA, Heelan MC (1998) Incidence of breast carcinoma-related lymphedema. Cancer 83:2776–2781CrossRefPubMed Petrek JA, Heelan MC (1998) Incidence of breast carcinoma-related lymphedema. Cancer 83:2776–2781CrossRefPubMed
2.
Zurück zum Zitat Veronesi U, Paganelli G, Galimberti V et al (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864–1867CrossRefPubMed Veronesi U, Paganelli G, Galimberti V et al (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864–1867CrossRefPubMed
3.
Zurück zum Zitat Scomersi S, Torelli L, Zanconati F et al (2012) Evaluation of a breast cancer nomogram for predicting the likelihood of additional nodal metastases in patients with a positive sentinel node biopsy. Ann Ital Chir 83:461–468PubMed Scomersi S, Torelli L, Zanconati F et al (2012) Evaluation of a breast cancer nomogram for predicting the likelihood of additional nodal metastases in patients with a positive sentinel node biopsy. Ann Ital Chir 83:461–468PubMed
4.
Zurück zum Zitat Van Zee KJ, Manasseh DM, Bevilacqua JL et al (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140–1151CrossRefPubMed Van Zee KJ, Manasseh DM, Bevilacqua JL et al (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140–1151CrossRefPubMed
5.
Zurück zum Zitat Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD (2008) A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 95:302–309CrossRefPubMed Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD (2008) A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 95:302–309CrossRefPubMed
6.
Zurück zum Zitat Kohrt HE, Olshen RA, Bermas HR et al (2008) New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 8:66CrossRefPubMedPubMedCentral Kohrt HE, Olshen RA, Bermas HR et al (2008) New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 8:66CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Barranger E, Coutant C, Flahault A et al (2005) An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91:113–119CrossRefPubMed Barranger E, Coutant C, Flahault A et al (2005) An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91:113–119CrossRefPubMed
8.
Zurück zum Zitat Hwang RF, Krishnamurthy S, Hunt KK et al. (2003) Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10:248–254CrossRefPubMed Hwang RF, Krishnamurthy S, Hunt KK et al. (2003) Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10:248–254CrossRefPubMed
9.
Zurück zum Zitat Soni N, Carmalt H, Gillett D et al (2005) Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol 31:958–964CrossRefPubMed Soni N, Carmalt H, Gillett D et al (2005) Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol 31:958–964CrossRefPubMed
10.
Zurück zum Zitat Lambert L, Ayers G, Hwang R, Hunt K, Ross M, Kuerer H et al (2006) Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 13:310–320CrossRefPubMed Lambert L, Ayers G, Hwang R, Hunt K, Ross M, Kuerer H et al (2006) Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 13:310–320CrossRefPubMed
11.
Zurück zum Zitat Cripe M, Beran L, Liang W, Sickle-Santanello B (2006) The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram. Am J Surg 192:484–487CrossRefPubMed Cripe M, Beran L, Liang W, Sickle-Santanello B (2006) The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram. Am J Surg 192:484–487CrossRefPubMed
12.
Zurück zum Zitat Alran S, de Rycke Y, Fourchotte V et al (2007) Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 14:2195–2201CrossRefPubMed Alran S, de Rycke Y, Fourchotte V et al (2007) Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 14:2195–2201CrossRefPubMed
13.
Zurück zum Zitat Ponzone R, Maggiorotto F, Mariani L et al (2007) Comparison of two models for the prediction of nonsentinel node metastases in breast cancer. Am J Surg 193:686–692CrossRefPubMed Ponzone R, Maggiorotto F, Mariani L et al (2007) Comparison of two models for the prediction of nonsentinel node metastases in breast cancer. Am J Surg 193:686–692CrossRefPubMed
14.
Zurück zum Zitat Van la Parra RF, Francissen CM, Peer PG, Ernst MF et al (2013) Assessment of the Memorial Sloan-Kettering Cancer Center nomogram to predict sentinel lymph node metastases in a Dutch breast cancer population. Eur J Cancer 49(3):564–571CrossRef Van la Parra RF, Francissen CM, Peer PG, Ernst MF et al (2013) Assessment of the Memorial Sloan-Kettering Cancer Center nomogram to predict sentinel lymph node metastases in a Dutch breast cancer population. Eur J Cancer 49(3):564–571CrossRef
15.
Zurück zum Zitat Klar M, Jochmann A, Foeldi M et al (2008) The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat 112(3):523–531CrossRefPubMed Klar M, Jochmann A, Foeldi M et al (2008) The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat 112(3):523–531CrossRefPubMed
16.
Zurück zum Zitat Hidara S, Harrabia I, Benregaya L et al (2011) Validation of nomograms to predict the risk of non-sentinel lymph node metastases in North African Tunisian breast cancer patients with sentinel node involvement. Breast 20:26–30CrossRef Hidara S, Harrabia I, Benregaya L et al (2011) Validation of nomograms to predict the risk of non-sentinel lymph node metastases in North African Tunisian breast cancer patients with sentinel node involvement. Breast 20:26–30CrossRef
17.
Zurück zum Zitat Tryggvadóttir L, Gislum M, Bray F et al (2010) Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol 49(5):624–631CrossRefPubMed Tryggvadóttir L, Gislum M, Bray F et al (2010) Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol 49(5):624–631CrossRefPubMed
18.
Zurück zum Zitat Sant M, Allemani C, Santaquilani M et al (2009) EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 45(6):931–991CrossRefPubMed Sant M, Allemani C, Santaquilani M et al (2009) EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 45(6):931–991CrossRefPubMed
19.
Zurück zum Zitat Giuliano A, Linda McCall L, Beitsch P et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. The American College of Surgeons Oncology Group Z0011 Randomized Trial. Ann Surg 252:426–433PubMed Giuliano A, Linda McCall L, Beitsch P et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. The American College of Surgeons Oncology Group Z0011 Randomized Trial. Ann Surg 252:426–433PubMed
20.
Zurück zum Zitat Gatzemeier W, Mann GB (2013) Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)–ACOSOG Z0011 Results and beyond. Breast 22(3):211–216CrossRefPubMed Gatzemeier W, Mann GB (2013) Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)–ACOSOG Z0011 Results and beyond. Breast 22(3):211–216CrossRefPubMed
21.
Zurück zum Zitat Noguchi M (2008) Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer. EJSO 34:129–134CrossRefPubMed Noguchi M (2008) Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer. EJSO 34:129–134CrossRefPubMed
22.
Zurück zum Zitat Langer I, Guller U, Viehl CT et al. (2009) Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Ann Surg Oncol 16(12):3366–3374CrossRefPubMed Langer I, Guller U, Viehl CT et al. (2009) Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Ann Surg Oncol 16(12):3366–3374CrossRefPubMed
23.
Zurück zum Zitat Ponzone R, Biglia N, Maggiorotto F et al (2003) Performance of sentinel node dissection as definitive treatment for node negative breast cancer patients. Eur J Surg Oncol 29:703–706CrossRefPubMed Ponzone R, Biglia N, Maggiorotto F et al (2003) Performance of sentinel node dissection as definitive treatment for node negative breast cancer patients. Eur J Surg Oncol 29:703–706CrossRefPubMed
24.
Zurück zum Zitat Giuliano AE, Morrow M, Duggal S, Julian TB (2012) Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer? Clin Exp Metastasis 29:687–692CrossRefPubMed Giuliano AE, Morrow M, Duggal S, Julian TB (2012) Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer? Clin Exp Metastasis 29:687–692CrossRefPubMed
25.
Zurück zum Zitat D’Angelo-Donovan DD, Dickson-Witmer D, Petrelli NJ (2012) Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations. Surg Oncol 21:196–200CrossRefPubMed D’Angelo-Donovan DD, Dickson-Witmer D, Petrelli NJ (2012) Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations. Surg Oncol 21:196–200CrossRefPubMed
26.
Zurück zum Zitat Wong SL, Edwards MJ, Chao C et al (2001) Predicting the status of the nonsentinel axillary nodes. Arch Surg 136:563–568CrossRefPubMed Wong SL, Edwards MJ, Chao C et al (2001) Predicting the status of the nonsentinel axillary nodes. Arch Surg 136:563–568CrossRefPubMed
27.
Zurück zum Zitat Joseph KA, El-Tamer M, Komenaka I, Troxel A et al (2004) Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Arch Surg 139:648–651CrossRefPubMed Joseph KA, El-Tamer M, Komenaka I, Troxel A et al (2004) Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Arch Surg 139:648–651CrossRefPubMed
28.
Zurück zum Zitat Hwang RF, Krishnamurthy S, Hunt KK, et al (2003) Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10:248–253CrossRefPubMed Hwang RF, Krishnamurthy S, Hunt KK, et al (2003) Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10:248–253CrossRefPubMed
29.
Zurück zum Zitat Boler DE, Uras C, Ince U et al (2012) Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases. Breast 21:518–523CrossRefPubMed Boler DE, Uras C, Ince U et al (2012) Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases. Breast 21:518–523CrossRefPubMed
30.
Zurück zum Zitat Turner RR, Chu K, Qi K, Hansen NM, Glass EC, Giuliano AE (2000) Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 89:574–581CrossRefPubMed Turner RR, Chu K, Qi K, Hansen NM, Glass EC, Giuliano AE (2000) Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 89:574–581CrossRefPubMed
32.
Zurück zum Zitat Weiser MR, Montgomery LL, Tan LK et al (2001) (2001) Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 8:145–149CrossRefPubMed Weiser MR, Montgomery LL, Tan LK et al (2001) (2001) Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 8:145–149CrossRefPubMed
33.
Zurück zum Zitat Degnim AC, Griffith KA, Sabel MS et al (2003) Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients: a metaanalysis. Cancer 98:2307–2315CrossRefPubMed Degnim AC, Griffith KA, Sabel MS et al (2003) Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients: a metaanalysis. Cancer 98:2307–2315CrossRefPubMed
34.
Zurück zum Zitat Reynolds C, Mick R, Donohue JH et al (1999) Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17:1720–1726PubMed Reynolds C, Mick R, Donohue JH et al (1999) Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17:1720–1726PubMed
35.
Zurück zum Zitat Chu KU, Turner RR, Hansen NM et al (1999) Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229:536–541CrossRefPubMedPubMedCentral Chu KU, Turner RR, Hansen NM et al (1999) Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229:536–541CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 11:927–933CrossRefPubMedPubMedCentral Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 11:927–933CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Hunt KK, Ballman KV, McCall LM, Boughey JC, Mittendorf EA et al. (2012) Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial. Ann Surg 256:428–436CrossRefPubMed Hunt KK, Ballman KV, McCall LM, Boughey JC, Mittendorf EA et al. (2012) Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial. Ann Surg 256:428–436CrossRefPubMed
38.
Zurück zum Zitat Goldstein NS, Mani A, Vicini F, Ingold J (1999) Prognostic features in patients with stage T1 breast carcinoma and a 0.5 cm or less lymph node metastasis. Am J Clin Pathol 111:21–28CrossRefPubMed Goldstein NS, Mani A, Vicini F, Ingold J (1999) Prognostic features in patients with stage T1 breast carcinoma and a 0.5 cm or less lymph node metastasis. Am J Clin Pathol 111:21–28CrossRefPubMed
39.
Zurück zum Zitat Eldweny H, Alkhaldy K, Alsaleh N et al (2012) Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node pilot study. J Egypt Natl Cancer Inst 24(1):23–30CrossRef Eldweny H, Alkhaldy K, Alsaleh N et al (2012) Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node pilot study. J Egypt Natl Cancer Inst 24(1):23–30CrossRef
40.
Zurück zum Zitat Meretoja TJ, Leidenius MHK, Heikkilä PS et al (2012) International multicenter tool to predict the risk of nonsentinel node metastasis in breast cancer. J Natl Cancer Inst 104(24):1888–1896CrossRefPubMed Meretoja TJ, Leidenius MHK, Heikkilä PS et al (2012) International multicenter tool to predict the risk of nonsentinel node metastasis in breast cancer. J Natl Cancer Inst 104(24):1888–1896CrossRefPubMed
41.
Zurück zum Zitat Stitzenberg KB, Meyer AA, Stern SL et al (2003) Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden. Ann Surg 237:607–612PubMedPubMedCentral Stitzenberg KB, Meyer AA, Stern SL et al (2003) Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden. Ann Surg 237:607–612PubMedPubMedCentral
42.
Zurück zum Zitat Moosavi SA, Abdirad A, Omranipour R et al (2014) Clinicopathological Factors Predicting Non-Sentinel Lymph Node Metastasis of Breast Cancer in Iran. Asian Pac J Cancer Prev 15:7049–7054CrossRefPubMed Moosavi SA, Abdirad A, Omranipour R et al (2014) Clinicopathological Factors Predicting Non-Sentinel Lymph Node Metastasis of Breast Cancer in Iran. Asian Pac J Cancer Prev 15:7049–7054CrossRefPubMed
43.
Zurück zum Zitat Ozmen V, Karanlik H, Cabioglu N et al (2006) Factors predicting the sentinel and nonsentinel lymph node metastases in breast cancer. Breast Cancer Res Treat 95:1–6CrossRefPubMed Ozmen V, Karanlik H, Cabioglu N et al (2006) Factors predicting the sentinel and nonsentinel lymph node metastases in breast cancer. Breast Cancer Res Treat 95:1–6CrossRefPubMed
44.
Zurück zum Zitat Coutant C, Olivier C, Lambaudie E, Fondrinier E, Marchal F, Guillemin F et al. (2009) Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol 27:2800–2808CrossRefPubMed Coutant C, Olivier C, Lambaudie E, Fondrinier E, Marchal F, Guillemin F et al. (2009) Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol 27:2800–2808CrossRefPubMed
45.
Zurück zum Zitat Smidt ML, Kuster DM, van der Wilt GJ et al (2005) Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in The Netherlands? Ann Surg Oncol 12:1066–1072CrossRefPubMed Smidt ML, Kuster DM, van der Wilt GJ et al (2005) Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in The Netherlands? Ann Surg Oncol 12:1066–1072CrossRefPubMed
46.
Zurück zum Zitat Lombardi A, Maggi S, Lo Russo M, Scopinaro F, Di Stefano D, Pittau MG et al (2011) Non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node: validation of five nomograms and development of a new predictive model. Tumori 97:749–755PubMed Lombardi A, Maggi S, Lo Russo M, Scopinaro F, Di Stefano D, Pittau MG et al (2011) Non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node: validation of five nomograms and development of a new predictive model. Tumori 97:749–755PubMed
47.
Zurück zum Zitat Soni NK, Carmalt HL, Gillett DJ, Spillane AJ et al (2005) Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol 31:958–964CrossRefPubMed Soni NK, Carmalt HL, Gillett DJ, Spillane AJ et al (2005) Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol 31:958–964CrossRefPubMed
48.
Zurück zum Zitat Kuo YL, Chen WC, Yao WJ et al (2013) Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison. Int J Surg 11(7):538–543CrossRefPubMed Kuo YL, Chen WC, Yao WJ et al (2013) Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison. Int J Surg 11(7):538–543CrossRefPubMed
49.
Zurück zum Zitat Hidar S, Harrabi I, Benregaya L, Fatnassi R, Khelifi A, Benabdelkader A et al. (2011) Validation of nomograms to predict the risk of non-sentinels lymph node metastases in North African Tunisian breast cancer patients with sentinel node involvement. Breast 20:26–30CrossRefPubMed Hidar S, Harrabi I, Benregaya L, Fatnassi R, Khelifi A, Benabdelkader A et al. (2011) Validation of nomograms to predict the risk of non-sentinels lymph node metastases in North African Tunisian breast cancer patients with sentinel node involvement. Breast 20:26–30CrossRefPubMed
50.
Zurück zum Zitat Sasada T, Murakami S, Kataoka T, Ohara M, Ozaki S, Okada M et al (2012) Memorial SloaneKettering Cancer Center nomogram to predict the risk of non-sentinel lymph node metastasis in japanese breast cancer patients. Surg Today 42:245–249CrossRefPubMed Sasada T, Murakami S, Kataoka T, Ohara M, Ozaki S, Okada M et al (2012) Memorial SloaneKettering Cancer Center nomogram to predict the risk of non-sentinel lymph node metastasis in japanese breast cancer patients. Surg Today 42:245–249CrossRefPubMed
51.
Zurück zum Zitat Amanti C, Lombardi A, Maggi S, Moscaroli A, Lo Russo M, Maglio R et al (2009) Is complete axillary dissection necessary for all patients with positive findings on sentinel lymph node biopsy? Validation of a breast cancer nomogram for predicting the likelihood of a non-sentinel lymph node. Tumori 95:153–155PubMed Amanti C, Lombardi A, Maggi S, Moscaroli A, Lo Russo M, Maglio R et al (2009) Is complete axillary dissection necessary for all patients with positive findings on sentinel lymph node biopsy? Validation of a breast cancer nomogram for predicting the likelihood of a non-sentinel lymph node. Tumori 95:153–155PubMed
52.
Zurück zum Zitat Van la Parra RF, Ernst MF, Bevilacqua JL, Mol SJ, Van Zee KJ, Broekman JM et al. (2009) Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram. Ann Surg Oncol 16:1128–1135CrossRef Van la Parra RF, Ernst MF, Bevilacqua JL, Mol SJ, Van Zee KJ, Broekman JM et al. (2009) Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram. Ann Surg Oncol 16:1128–1135CrossRef
53.
Zurück zum Zitat Gur AS, Unal B, Ozbek U, Ozmen V, Aydogan F, Gokgoz S et al (2010) Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol 36:30–35CrossRefPubMed Gur AS, Unal B, Ozbek U, Ozmen V, Aydogan F, Gokgoz S et al (2010) Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol 36:30–35CrossRefPubMed
54.
Zurück zum Zitat Poirier E, Sideris L, Dube P, Drolet P, Meterissian SH (2008) Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: the Canadian experience. Ann Surg Oncol 15:2562–2567CrossRefPubMed Poirier E, Sideris L, Dube P, Drolet P, Meterissian SH (2008) Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: the Canadian experience. Ann Surg Oncol 15:2562–2567CrossRefPubMed
55.
Zurück zum Zitat Pinero A, Canteras M, Moreno A, Vicente F, Gimenez J, Tocino A et al (2013) Multicenter validation of two nomograms to predict non-sentinel node involvement in breast cancer. Clin Transl Oncol 15:117–123CrossRefPubMed Pinero A, Canteras M, Moreno A, Vicente F, Gimenez J, Tocino A et al (2013) Multicenter validation of two nomograms to predict non-sentinel node involvement in breast cancer. Clin Transl Oncol 15:117–123CrossRefPubMed
56.
Zurück zum Zitat Coufal O, Pavlik T, Fabian P, Bori R, Boross G, Sejben I et al (2009) Predicting nonsentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population? Pathol Oncol Res 15:733–740CrossRefPubMed Coufal O, Pavlik T, Fabian P, Bori R, Boross G, Sejben I et al (2009) Predicting nonsentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population? Pathol Oncol Res 15:733–740CrossRefPubMed
57.
Zurück zum Zitat van den Hoven I, Kuijt GP, Voogd AC et al (2010) Value of Memorial Sloan Kettering Cancer Center nomogram in clinical decision making for sentinel lymph node-positive breast cancer. Br J Surg 97:1653–1658CrossRefPubMed van den Hoven I, Kuijt GP, Voogd AC et al (2010) Value of Memorial Sloan Kettering Cancer Center nomogram in clinical decision making for sentinel lymph node-positive breast cancer. Br J Surg 97:1653–1658CrossRefPubMed
58.
Zurück zum Zitat Sanjuan A, Escaramis G, Vidal-Sicart S, Illa M, Zanon G, Pahisa J et al (2010) Predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement: evaluation of two scoring systems. Breast J 16:134–140CrossRefPubMed Sanjuan A, Escaramis G, Vidal-Sicart S, Illa M, Zanon G, Pahisa J et al (2010) Predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement: evaluation of two scoring systems. Breast J 16:134–140CrossRefPubMed
59.
Zurück zum Zitat Moghaddam Y, Falzon M, Fulford L, Williams NR, Keshtgar MR (2010) Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer. Br J Surg 97:1646–1652CrossRefPubMed Moghaddam Y, Falzon M, Fulford L, Williams NR, Keshtgar MR (2010) Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer. Br J Surg 97:1646–1652CrossRefPubMed
60.
Zurück zum Zitat Fougo JL, Senra FS, Araujo C, Dias T, Afonso M, Leal C et al (2011) Validating the MSKCC nomogram and a clinical decision rule in the prediction of non-sentinel node metastases in a Portuguese population of breast cancer patients. Breast 20:134–140CrossRefPubMed Fougo JL, Senra FS, Araujo C, Dias T, Afonso M, Leal C et al (2011) Validating the MSKCC nomogram and a clinical decision rule in the prediction of non-sentinel node metastases in a Portuguese population of breast cancer patients. Breast 20:134–140CrossRefPubMed
61.
Zurück zum Zitat Forza Operativa sul Carcinoma Mammario. Linee guida sulla diagnosi,il trattamento e la riabilitazione. Aggiornamento 2005 (2005) Attualità Senologia 46:33–106 Forza Operativa sul Carcinoma Mammario. Linee guida sulla diagnosi,il trattamento e la riabilitazione. Aggiornamento 2005 (2005) Attualità Senologia 46:33–106
62.
Zurück zum Zitat Woznick A, Franco M, Bendick P, Benitez PR (2006) Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal? Am J Surg 191:330–333CrossRefPubMed Woznick A, Franco M, Bendick P, Benitez PR (2006) Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal? Am J Surg 191:330–333CrossRefPubMed
63.
Zurück zum Zitat Cserni G (2007) Comparison of different validation studies on the use of the Memorial-Sloan Kettering Cancer Center nomogram predicting nonsentinel node involvement in sentinel node–positive breast cancer patients. Letters to the Editor. Am J Surg 194:699–700CrossRefPubMed Cserni G (2007) Comparison of different validation studies on the use of the Memorial-Sloan Kettering Cancer Center nomogram predicting nonsentinel node involvement in sentinel node–positive breast cancer patients. Letters to the Editor. Am J Surg 194:699–700CrossRefPubMed
64.
Zurück zum Zitat Kocsis L, Svebis M, Boross G et al (2004) Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am Surg 70:1019–1024PubMed Kocsis L, Svebis M, Boross G et al (2004) Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am Surg 70:1019–1024PubMed
65.
Zurück zum Zitat Soni NK, Carmalt HL, Gillett DJ, Spillane AJ (2005) Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol 31:958–964CrossRefPubMed Soni NK, Carmalt HL, Gillett DJ, Spillane AJ (2005) Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol 31:958–964CrossRefPubMed
66.
Zurück zum Zitat Degnim AC, Reynolds C, Pantvaidya G et al (2005) Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 190:543–550CrossRefPubMed Degnim AC, Reynolds C, Pantvaidya G et al (2005) Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 190:543–550CrossRefPubMed
67.
Zurück zum Zitat Gur AS, Unal B, Johnson R, Ahrendt G, Bonaventura M, Gordon P et al (2009) Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg 208:229–235CrossRefPubMed Gur AS, Unal B, Johnson R, Ahrendt G, Bonaventura M, Gordon P et al (2009) Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg 208:229–235CrossRefPubMed
68.
Zurück zum Zitat D’Eredità G, Troilo VL, Giardina C et al (2010) Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms. Clin Breast Cancer 10(6):445–451CrossRefPubMed D’Eredità G, Troilo VL, Giardina C et al (2010) Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms. Clin Breast Cancer 10(6):445–451CrossRefPubMed
69.
Zurück zum Zitat Kamath VJ, Giuliano R, Dauway EL et al (2001) Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-Echelon nodes in the axilla. Arch Surg 136:688–692CrossRefPubMed Kamath VJ, Giuliano R, Dauway EL et al (2001) Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-Echelon nodes in the axilla. Arch Surg 136:688–692CrossRefPubMed
70.
Zurück zum Zitat Rahusen FD, Torrenga H, van Diest PJ, et al (2001) Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 136:1059–1063CrossRefPubMed Rahusen FD, Torrenga H, van Diest PJ, et al (2001) Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 136:1059–1063CrossRefPubMed
71.
Zurück zum Zitat Donker M, van Tienhoven G, Straver ME et al. (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet 15:1303–1310CrossRefPubMedPubMedCentral Donker M, van Tienhoven G, Straver ME et al. (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet 15:1303–1310CrossRefPubMedPubMedCentral
Metadaten
Titel
Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population
verfasst von
Naveen Padmanabhan
Muhamed Faizal Ayub
Khadher Hussain
Ann Kurien
Selvi Radhakrishna
Publikationsdatum
05.12.2015
Verlag
Springer India
Erschienen in
Indian Journal of Surgical Oncology / Ausgabe 4/2015
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-015-0431-y

Weitere Artikel der Ausgabe 4/2015

Indian Journal of Surgical Oncology 4/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.